PULMONARY FUNCTION TESTING CENTER BUSINESS PLAN

I. Executive Summary

Company Description

The clinic is named Houston Respiratory Diagnostics, reflecting its focus on precision lung testing and its location in Houston, Texas. We operate in the outpatient respiratory diagnostics sector, delivering specialist pulmonary function testing (PFTs) and respiratory analysis. Our core services are full plethysmography, diffusion capacity and gas analysis, and standardized spirometry, all performed under a board-certified Medical Director and by certified pulmonary technologists. We translate primary-care respiratory complaints into high-accuracy diagnostic data that referring physicians use to make treatment decisions.

We run scheduled and urgent outpatient testing, physician referrals intake, result interpretation, and data reporting integrated with electronic health records. What sets us apart is our exclusive focus on pulmonary diagnostics, latest plethysmography/gas-analysis equipment, and standardized quality controls that produce reproducible, clinician-ready reports. Our primary market is adult patients and referring providers across Greater Houston with suspected or chronic respiratory disease. Short-term goals are to launch in 2026, achieve steady referral volume, and validate workflows; long-term goals are to expand capacity regionally and add advanced diagnostic services and value-based testing contracts.

Problem

Millions of Americans experience persistent respiratory symptoms yet face long waits for specialized testing; hospital pulmonary labs report backlogs with wait times of weeks to months, and generalized testing centers often lack the focus needed for complex respiratory conditions. These delays increase clinical uncertainty for referring physicians, extend time to treatment, and fragment care.

Delayed diagnosis correlates with progression of conditions such as chronic obstructive pulmonary disease and interstitial lung disease, worsening patient outcomes and raising downstream costs. A dedicated outpatient pulmonary function testing clinic in Houston (opening 2026) staffed by a board-certified Medical Director and certified pulmonary technologists, and equipped with plethysmography and gas analysis, is needed to provide high-accuracy data and shorten time to specialist treatment.

Solution

Patients with respiratory symptoms face long waits and scattered testing that delay treatment for asthma, COPD, and other lung diseases. We offer a dedicated outpatient pulmonary function testing clinic that shortens diagnosis time and raises diagnostic quality for referring physicians by providing specialized, timely testing outside hospital labs.

Services include spirometry, lung volumes, and diffusion capacity testing in a respiratory-focused clinic with rapid appointments and results delivered within 24–48 hours to physicians; staff are certified technologists using state-of-the-art equipment to improve accuracy and reduce downstream healthcare use.

One-liner: fast, focused respiratory testing delivered by certified technologists.

Mission Statement

We empower physicians with high-quality, rapid diagnostic data so patients breathe easier and sooner. By specializing in pulmonary function testing and applying clinical expertise, we remove barriers to accurate, timely diagnosis and deliver a seamless, professional testing experience. Our goal is to be the preferred diagnostic partner for the medical community, committed to excellence, patient-centered care, and measurable improvement in respiratory health.

Key Success Factors

Rapid turnaround, strong returns, clinical credibility, referral channels, and patient experience drive our success.

• Rapid result turnaround provides a clear competitive edge over hospital labs.
• High IRR of 45.92% and immediate breakeven show robust unit economics and low capital risk.
• Certified technologists deliver diagnostic accuracy that builds physician trust.
• Dedicated Physician Liaison secures a steady stream of referrals from local practices.
• Specialized outpatient setting improves patient experience, compliance, and satisfaction.

Financial Summary

The center projects rapid, high-margin growth driven by specialty services and lean staffing.

Financial requirements: minimum cash $837,000 (required Feb-2026); breakeven Jan-2026; one-month payback on initial capital; anticipated IRR 45.92% and ROE 26.48%.

Overall outlook: strong early breakeven and high-return growth through 2030.

Funding Requirements

We require USD 837,000 to launch the Pulmonary Function Testing Center; year-one revenue is projected at USD 1.94M, rising to USD 11.54M by 2030, EBITDA from USD 1.14M to USD 9.26M, IRR 45.92%, ROE 26.48%, breakeven in month one with a one-month payback on initial capital.